Article List

WPRIM Management System> DCMS> Korean Journal of Urology> 2009> 50> 8

Volume: 50 Issue: 8

1. Comparison of the Urinary Melanoma Antigen Gene Expression (MAGE) Test and Urinary Cytology for Bladder Cancer Screening.	Page:739—743
2. Bibliometrics Review of the Korean Journal of Urology from 1960 to 2008: Trends and Future Directions.	Page:731—738
3. Intratesticular Varicocele Associated with Ipsilateral Extratesticular Varicocele.	Page:822—824
4. Large Prostatic Calculi Causing Urethral Obstruction.	Page:819—821
5. Newly Discovered Pseudoaneurysm after Embolization of a Renal Arteriovenous Fistula with a Pseudoaneurysm following a Renal Stab Wound.	Page:816—818
6. Sarcomatoid Urothelial Carcinoma of the Renal Pelvis with Extremely Aggressive Clinical Behavior.	Page:812—815
7. Effect of Mitomycin-C on Experimentally Induced Urethral Stricture in Rats.	Page:805—811
8. Protective Effect of Hyaluronic Acid on Cyclophosphamide-Induced Cystitis in Rats.	Page:797—804
9. Significance of Intraprostatic Inflammation in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia.	Page:791—796
10. The Efficacy of Retrograde Intrarenal Surgery (RIRS) in the Management of Renal Stone Disease.	Page:786—790
11. The Factors Affecting Non-Urologic Postoperative Complications after Laparoscopic Surgery in the Urologic Area.	Page:780—785
12. Tumor Exposure and Cold Ischemia Using a LapSac(R) in Partial Nephrectomy by Video-Assisted Minilaparotomy Surgery (VAMS).	Page:774—779
13. Five-Year Outcomes of the IRIS Procedure for the Treatment of Female Stress Urinary Incontinence: Comparison with the TVT Procedure.	Page:767—773
14. Incidence and Risk Factors of Postoperative De Novo Voiding Dysfunction following Midurethral Sling Procedures.	Page:762—766
15. Efficacy and Safety of Intravenous Propofol Anesthesia during Transrectal Ultrasound-Guided Prostate Biopsy.	Page:757—761
16. The Preoperative Factors Predicting a Positive Frozen Section during Radical Prostatectomy for Prostate Cancer.	Page:751—756
17. CyberKnife(TM) for the Treatment of Non-Metastatic Prostate Cancer.	Page:744—750